Glenmark gets USFDA nod for plaque psoriasis treatment drug

"Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Clobetasol Propionate Foam, 0.05 percent (emulsion formulation)," Glenmark said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2N704z1